Based on the frequently used biomarkers, ER, PR, Her2, and Ki-67, BC is classified into four specific molecular subtypes: luminal A, luminal B, Her2-enriched, and triple negative breast cancer (TNBC) in which ER, PR, and Her2 are all negative [8]. Here, ESR1 is linked to triple-negative breast carcinoma.